ACTA ENDOCRINOLOGICA (BUC)

The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

Year Volume Issue First page
10.4183/aeb.
Author
Title
Abstract/Title
From through

  • Case Series

    Ilie I, Ciubotaru V, Tulin A, Hortopan D, Caragheorgheopol A, Purice M, Neamtu C, Elian VI, Banica A, Oprea L, Musat M

    The Multifarious Cushing’s – Lessons from a Case Series

    Acta Endo (Buc) 2019 15(2): 261-269 doi: 10.4183/aeb.2019.261

    Abstract
    Endogenous Cushing’s syndrome is rare, with an incidence of 0.7–2.4 per a million people a year. Clinical presentation of Cushing syndrome can be pleomorphic, and establishing diagnosis can be difficult. Early recognition and rapid control of hypercortisolaemia are necessary to decrease morbidity and mortality in these patients. We report a series of 6 endogenous Cushing’s syndromes of different etiologies (4 Cushing’s disease and 2 adrenal Cushing’s syndrome) assessed in our endocrine department over a decade (2009-2019). In order to highlight the diversity of clinical forms, diagnostic tools and specific management of this condition we labelled each case suggestively: the typical Cushing’s disease, the Pseudo Cushing’s, the elusive Cushing’s disease, the mild autonomous cortisol hypersecretion, Cushing’s syndrome in pregnancy and Cushing’s disease with thromboembolism. We discussed their particularities which were revelatory for the diagnosis, such as dermatologic, cardiovascular, musculoskeletal, neuropsychiatric, or reproductive signs, reviewing literature for each manifestation. We also discuss the commonalities and differences in laboratory and imagistic findings. Therapeutic approach can also differ with respect to the particular condition of each patient and the multiple choices of therapy will be reviewed.
  • Case Report

    Borrayo G, Basurto L, González-Escudero E, Diaz A, Vázquez A, Sánchez L, Hernández-González GO, Barrera S , Degollado JA, Córdova N, Avelar F

    Tg/Hdl-C Ratio as Cardio-Metabolic Biomarker even in Normal Weight Women

    Acta Endo (Buc) 2018 14(2): 261-267 doi: 10.4183/aeb.2018.261

    Abstract
    Context. Despite that the Triglycerides/High Density Lipoprotein Cholesterol (TG/HDL-C) ratio has been associated with insulin resistance and cardiovascular disease, some outcomes differ between populations. Objective. The objective of this study was to evaluate the association between TG/HDL-C ratio and cardio-metabolic risk factors in both obese and normal weight women. Design. Cross sectional, from January to December of 2015. Subjects and Methods. Two hundred and fifty three women aged 40 to 60 years. Anthropometric and laboratory measurements were performed. Insulin resistance was measured by the homeostasis model assessment for insulin resistance (HOMA-IR). All participants underwent a Doppler ultrasound to measure intima-media thickness of carotid artery (cIMT). Results. TG/HDL-C ratio correlated with body mass index (r=0.194, p=0.01), and visceral adipose tissue (r=0.193, p=0.002). Additionally, TG/HDL-C correlated with glucose (r=0.367, p=0.001), insulin (r=0.354, p=0.001) and HOMA-IR (r=0.396 p=0.001). TG/HDL-C was associated with prediabetes, Odds Ratio (OR) was 1.83 (95%CI 1.07-3.13) and insulin resistance 3.27 (95%CI 1.78- 6.01), and this risk remains in normal weight women 4.7 (95%CI 1.2-17.81) for prediabetes and 4.38 (95%CI 1.42- 13.84) for insulin resistance. No significant risk for cIMT. Conclusion. A TG/HDL-C ratio ≥ 3.0 is a potential risk factor for prediabetes and insulin resistance in women 40-60 years, even in normal weight women.
  • Perspectives

    Cvasciuc IT, Fraser S, Lansdown M

    Retrosternal Goitres: A Practical Classification

    Acta Endo (Buc) 2017 13(3): 261-265 doi: 10.4183/aeb.2017.261

    Abstract
    Background. There is no standard definition for goitres extending below the thoracic inlet and no clear guidelines for pre-operative planning of surgery. The aim of this study is a practical classification of retrosternal goitres (RSG) based on the anatomical , radiological shape and size of the thyroid. Methods. Retrospective analysis of all thyroidectomies performed in a referral centre between January 2012 and December 2016. Patients with RSGs had a pre-operative CT scan of neck/thorax. Imaging was reviewed to establish features to predict the difficulty of delivering the goitre through the neck incision and to advise the best surgical approach. Results. 847 thyroidectomies were performed with n=98 involving RSGs. TypeA (n=47) are RSG with a shape of a “cone” or pyramid with the apex pointing down. Cervicotomy is the usual approach. TypeB (n=39) are goitres with a shape of a “pyramid’ with the apex pointing up, cervicotomy with ± manubriotomy or sternotomy ± thoracotomy maybe required. TypeC (n=6) are thyroid enlargements in the mediastinum connected by a pedicle with the thyroid in the neck. A cervical approach ± manubriotomy or sternotomy ± thoracotomy is needed. TypeD (n=6) are true intrathoracic or “forgotten” goitres. Sternotomy is indicated for thyroids in the anterior mediastinum though a thoracic approach for those located in the posterior mediastinum might be needed. Conclusion. The shape and size of goitres is important in carefully planning surgery. CT imaging with cross-sectional reconstruction should be analysed before operation. The proposed classification helps treatment planning and allows comparison of outcomes by anatomical complexity.
  • Book Review

    Badiu C

    Diagnostic Pathology: Endocrine

    Acta Endo (Buc) 2022 18(2): 262-262 doi: 10.4183/aeb.2022.262

  • Images in Endocrinology

    Huang SP, Zhou HW, Li D, Hu MR, Qin C

    A Giant Non-Functional Parathyroid Cyst

    Acta Endo (Buc) 2020 16(2): 262-262 doi: 10.4183/aeb.2020.262

  • General Endocrinology

    Chiriac S, Stanciu C, Negru R, Trifan A

    Assessment of Adrenocortical Dysfunction in Patients with Stable Liver Cirrhosis

    Acta Endo (Buc) 2016 12(3): 262-267 doi: 10.4183/aeb.2016.262

    Abstract
    Introduction. Relative adrenal insufficiency (RAI) is common in the setting of critical illness as well as in hemodynamically instable cirrhotic patients with sepsis. Several studies have also shown that RAI is frequent in patients with stable cirrhosis without sepsis. The aim of this study was to prospectively assess the incidence of RAI in patients with stable cirrhosis. Patients and Methods. Forty-seven patients with hemodynamically stable liver cirrhosis without sepsis were prospectively included. RAI, assessed by using low doseshort Synacthen test (LD-SST), was defined as either a basal total cortisol concentration below 3.6 μg/dL or a peak total serum cortisol ≤ 16 μg/dL at 30 min after stimulation. Results. RAI was present in 10 (21.3%) of 47 cirrhotic patients. Peak cortisol level was negatively correlated with the severity of cirrhosis evaluated by Child- Turcotte-Pugh (CTP) (r=-0.46; P=0.001) and Model for End- Stage Liver Disease (MELD) (r=-0.51; P=0.001) scores. The frequency of RAI increased from CTP-A (10%) to CTP-B (30%) to CTP-C (60%). Conclusion. RAI diagnosed by LD-SST is frequent in patients with stable cirrhosis and is related to the severity of liver disease. Further studies are needed to define clinical importance of RAI in stable cirrhotic patients.
  • Actualities in medicine

    Galoiu S

    Insights into Obesity’s Pathogenesis and Pharmacological Management

    Acta Endo (Buc) 2015 11(2): 262-263 doi: 10.4183/aeb.2015.262

    Abstract
    Obesity is an increasing public health problem, the fifth leading risk for global deaths according to WHO. It is associated with major comorbidities, such as type 2 diabetes mellitus, ischemic heart disease, hypertension, dyslipidemia, sleep apnea, osteoarthritis, nonalcoholic fatty liver disease and depression. The obesity pathogenesis increasingly became clearer. It is thought to be the result of a neuroendocrine dysregulation of energy intake and energy expenditure. One of the most studied cytokines involved in obesity, leptin is secreted from adipose tissue, proportional to fat mass. It inhibits neuropeptide Y/Agouti-related peptide neurons and activates pro-opiomelanocortin (POMC)/ cocaine amphetamine-related transcript neurons in the hypothalamus, resulting in an anorectic effect.
  • Endocrine Care

    Mohammadkhani G, Jalilzadeh Afshari P., Jalaei S., Nasli Esfahani E. , Majidi H

    Auditory Event Related Potentials in Type 1 Diabetes Mellitus

    Acta Endo (Buc) 2013 9(2): 263-272 doi: 10.4183/aeb.2013.263

    Abstract
    Background. Type 1 diabetes mellitus is a common disorder which causes a variety of complications such as cognitive deficits in central nervous system. Auditory P300 event related potential is a wellestablished neurophysiologic approach in the assessment of cognitive performance. In this study, we aimed to evaluate the cognitive performance in insulin dependent diabetic patients by auditory event related potentials. Methods. In this descriptive analytical and non-interventional study, auditory P300 event related potential was measured in oddball paradigm by using two tone burst stimuli (1000 & 2000 Hz) on 25 diabetic patients and 25 age, education and sex matched healthy controls, with mean age 28.76±4.1 in patients and 29.68±3.6 in controls. Results. The mean P300 latency of the diabetic patients was significantly prolonged and the mean P300 amplitude of the diabetic patients was significantly lower when compared with that of controls at all electrode sites (p<0.01). Also there was a strong correlation between P300 latency and glucose level, HbA1c and diabetes duration (p<0.01). Conclusion. Auditory information processing is slower and the speed of information categorizing is lower in diabetic patients than in controls.
  • General Endocrinology

    Mihaescu G, Olinescu R, Oancea F

    Metabolic syndrome may be improved following a long-time administration of a nutritive supplement containing embryonary peptides

    Acta Endo (Buc) 2005 1(3): 263-270 doi: 10.4183/aeb.2005.263

    Abstract References
    Metabolic Syndrome (MS) is a polymorph disease with a high frequency especially in older age. Any randomized study with nonhospitalized subjects might include those bearing MS, that greatly influenced the final results. Eighty subjects aged 50-75 years (38 men and 42 women) had consumed daily 4 caps of purified Embryonary Peptides (EP) for 60 days. The samples of blood from each subject were obtained before and after administration. Therefore, each subject was his own control. In all subjects, after administration, regardless of the MS presence, total cholesterol and LDL-cholesterol had decreased approximately 30 % as compared with the initial values. Significant decreases of insulin and cortisol were also observed, but associated with modifications of PSA, CEA and IGF-l. The magnitude of these changes was lower in subjects with MS. The long-lasting modifications induced by EP seem to have an adaptive-regulatory character, affecting the lipid metabolism (already modified in MS), as well as some pathways from steroid biosynthesis. Thus, EP might act similarly to some stimulatory factors, such as IGF-1, in a reversible stage of MS.
    1. Reaven GM. Role of insulin resistance in human diseases. Diabetes 1988; 37: 1595-1599. [CrossRef]
    2. Despres JP. Potential contribution of metformin to the management of cardio-vascular risk in patients with abdominal obesity and type 2 diabetes. Diab. Metab. 2003; 29: 6S53-6S59.
    3. Hancu N., Roman G., Nita C. et al. Metabolic Syndrome - Practical Approach. Roman. J. Inter, Med. 2004; 42(2): 237-246.
    4. Mota M., Panus C., Mota E. et al. Metabolic Syndrome - a multifaced disease. Roman. J. Intern. Med. 2004; 42(2): 247-256.
    5. Gruia IM. Olinescu R., Mihaescu G. The modification of oxidative stress in elderly after Orgasel and Humanofort treatment. Infomedica 1997; 11: 40-44.
    6. Mihaescu G., Olinescu R., Oancea F., Significant modifications of lipid metabolism in aged persons following the administration of a nutritive supplement. Rom. J. Intern. Med. 2006 - in press.
    7. Jaffiel C. Le Syndrome Polymetabolique ou Obesite Maligne. Roum. J. Endocrinol. Metabolism, 2005; 4(3): 14-20.
    8. Vaughan CJ., Murphy MB., Buckley BM., Statins do more than lower cholesterol. Lancet l996; 348-352.
    9. Serpoi G., Cucu C., Transaminases are significantly increased in patients with metabolic syndrome when compared with obese controls. Acta Endocrinologica 2005; 1(1): 19-30. [CrossRef]
    10. Olinescu R., Smith TL., Physiologic Effects of Oxidative Stress: Aging, in: Olinescu R. and Smith TL, Free Radicals in Medicine, Nova Science Publ.Inc. New York, 2002; 120-126.
    11. Kummerow FA, Olinescu R., Fleischer L. et al. The relationship of oxidized lipids to coronary artery stenosis. Atherosclerosis, 2000; 149: 181-190.
    12. Marcus MA., White GC., Insulin sensitivity and serum triglyceride level in obese white and black women. Metabolism, 1999; 48: 143-149.
    13. Czeh MP. New perspectives on the mechanism of insulin action. Recent Progress Hormone Res. 1984; 40: 347-360.
    14. Landin WS., Lappas G., Serum IGF-1 in random population sample of men and women. Clin. Endocrinol. Oxford, 1994; 41: 351-357.
  • General Endocrinology

    Csép K, Gyongyi Dudutz, Marta Vitay, Pascanu I, Banescu C, Koranyi L, Rosivall L

    The Relationship Between The PRO12ALA Polymorphism Of The PPAR?2 Gene And The Metabolic Syndrome In A Population Of Central Romania Diagnosed According To The Idf Criteria

    Acta Endo (Buc) 2008 4(3): 263-271 doi: 10.4183/aeb.2008.263

    Abstract
    The nuclear receptor coding PPARγ2 (PEROXISOME PROLIFERATORACTIVATED RECEPTOR-GAMMA; *601487) gene influences the lipid and carbohydrate metabolism via multiple pathways and is a candidate for the metabolic syndrome. In this paper we studied the relationship of the CCG (Pro) → GCG (Ala) polymorphism of the gene with the metabolic syndrome diagnosed according to the criteria recommended by the International Diabetes Federation (IDF) in 2005, in a population from central Romania. We have carried out a case-control study on 144 patients and 73 control subjects. Routine biochemical assays have been carried out, fasting insulinemia was measured by ELISA, and insulin sensitivity was assessed by calculating the HOMA and QUICKI indices. Genetic analysis was done by PCR followed by digestion with the restriction enzyme BstU I. The results show that the Pro12 allele had a higher frequency in the group of patients as compared to the healthy controls (76 vs. 65.7%, p<0.05). The risk for developing the metabolic syndrome in the presence of the Pro12 allele in a homozygous combination was found to be low but statistically significant (PP vs. PA + AA: OR = 1.98, CI 95% 1.04 -3.78, p = 0.046). In conclusion, in the local population, the Pro12 allele of the PPARG2 gene seems to contribute to the hereditary predisposition of the metabolic syndrome diagnosed according to the recommendations of the IDF, most likely as part of a polygenic system. Probably the absence of the protective Ala12 allele increases the risk for developing the disease.